Skip to main content
Back to Insight Partners

Insight Partners's Pharmaceutical Portfolio

Browse 7 Pharmaceutical companies funded by Insight Partners. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
7
Total Funding in Pharmaceutical
$437.0M

Pharmaceutical Portfolio Companies (7)

Export
Clinical TrialsPharmaceuticalTherapeutics

PhaseV provides AI-driven solutions for efficient clinical development and operations.

Boston, United States
May 2025
$50.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

San Diego, United States
September 2024
$50.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.

Durham, United States
January 2024
$55.0M
Series A

Founder Contacts

30,000+ verified contacts

Agentic AIArtificial Intelligence (AI)Enterprise SoftwareLife ScienceManufacturingPharmaceutical

The industry's first agentic AI manufacturing platform built for a world beyond paper and legacy MES

Jersey City, United States
March 2023
$65.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Cambridge, United States
June 2022
$70.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.

Atlanta, United States
June 2022
$27.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Insight Partners's Full Portfolio

View all companies funded by Insight Partners across every industry and funding stage.

View Full Insight Partners Portfolio